Article
Different Mechanisms in Doxorubicin-Induced Neurotoxicity: Impact of BRCA Mutations
15 May 2025
Abstract excerpt
The genotoxic drug doxorubicin (Dox) remains one of the most powerful chemotherapeutic options available for a wide range of cancers including breast, ovarian, and other cancers. However, emerging evidence links Dox treatment with chemotherapy-induced cognitive impairment, a condition that is popularly referred to as Dox-induced neurotoxicity or "chemobrain", which limits the use of the drug. There are no...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
